ReviewCurrent pharmaceutical design2026
Polymeric Microneedles: Advancing Potential Through Innovative Manufacturing, Polymer Design, and Characterization Techniques.
Review in Current pharmaceutical design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microneedles (MNs) represent a transformative technology in pharmaceutics, offering a minimally invasive method for drug delivery that enhances patient compliance and therapeutic efficacy. By enabling transdermal administration, MNs provide a promising option to conventional routes of drug delivery, such as injections and oral administration, which may cause discomfort and lead to poor adherence. This review provides a comprehensive analysis of polymeric MNs, with a particular focus on their fabrication techniques, polymer selection strategies, and pharmaceutical characterization methods. It critically examines the latest advancements in manufacturing approaches, emphasizing the role of biocompatible and biodegradable polymers in enhancing drug solubility, stability, and controlled release. This review provides insights into the current landscape of polymeric MN applications in drug delivery , highlighting their potential to revolutionize therapeutic interventions across diverse medical fields. Ongoing advancements in polymeric MN technology could lead to significant improvements in patient outcomes, positioning MNs as a cornerstone of the next generation of drug delivery systems.
Indexed as
Identifiers
40735998What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.